Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
54.62
+0.21 (0.39%)
Nov 20, 2024, 4:00 PM EST - Market closed
Agios Pharmaceuticals Employees
As of December 31, 2023, Agios Pharmaceuticals had 386 total employees, including 383 full-time and 3 part-time employees. The number of employees decreased by 7 or -1.78% compared to the previous year.
Employees
386
Change (1Y)
-7
Growth (1Y)
-1.78%
Revenue / Employee
$85,158
Profits / Employee
$1,746,912
Market Cap
3.11B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
BrightSpring Health Services | 35,000 |
Bausch Health Companies | 20,270 |
Amedisys | 19,000 |
Inari Medical | 1,300 |
PTC Therapeutics | 1,055 |
Xenon Pharmaceuticals | 259 |
Merus | 229 |
Dyne Therapeutics | 141 |
AGIO News
- 15 days ago - Agios to Present New Data on Mitapivat and Tebapivat in Rare Blood Disorders at 66th ASH Annual Meeting and Exposition - GlobeNewsWire
- 20 days ago - Agios Pharmaceuticals, Inc. (AGIO) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 21 days ago - Agios Reports Business Highlights and Third Quarter 2024 Financial Results - GlobeNewsWire
- 5 weeks ago - Agios to Webcast Conference Call of Third Quarter 2024 Financial Results on October 31, 2024 - GlobeNewsWire
- 2 months ago - Agios Announces FDA Orphan Drug Designation Granted to Tebapivat (AG-946) for Treatment of Myelodysplastic Syndromes (MDS) - GlobeNewsWire
- 2 months ago - Agios to Present at the 2024 Cantor Global Healthcare Conference on September 18, 2024 - GlobeNewsWire
- 3 months ago - Agios' Mitapivat: A Potential Blockbuster In Thalassemia Treatment - Seeking Alpha
- 3 months ago - Agios to Receive $1.1 Billion in Milestone Payments Following FDA Approval of Vorasidenib - GlobeNewsWire